Major Bismuth Subsalicylate Tablet, Chewable
Product Images NDC 68788-8239

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Major Bismuth Subsalicylate (NDC 68788-8239). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Schematic, Timelinedescription Automatically Generated With Medium Confidence (69b9999f C2e5 43a6 891f 0e24d3c343a4 00)

Schematic, Timelinedescription Automatically Generated With Medium Confidence (69b9999f C2e5 43a6 891f 0e24d3c343a4 00)
This is a description of Bismuth Subsalicylate tablets. Each tablet contains 262mg of Bismuth subsalicylate, which helps relieve upset stomach and diarrhea. It is a generic equivalent of Pepto-Bismol. The tablets are made by Major Pharmaceuticals in Livonia, MI, and are round and pink, with the imprint G122. However, children and teenagers recovering from chickenpox or flu-like symptoms should avoid using this medication. People allergic to aspirin or taking other salicylate products should also avoid using it. The packaging contains important drug information, and caution should be taken to avoid excessive heat. The details of the product including its package size, expiration date, lot number, batch number, and production number are mentioned on the package. The text includes instructions in Spanish and contains a chart log for billing and insurance purposes.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.